$BNET
BION ENVIRONMENTAL TECHNOLOGIES INC Stock $bnet

$bnet Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-Q Financial Statement

#000107997324000236 Filed on February 14, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2022 Q4
Revenue	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$526.6K	$629.0K	$607.5K
YoY Change	-37.16%	3.54%	-1.69%
% of Gross Profit
Research & Development	$6.144K	$7.431K	$15.15K
YoY Change	-74.66%	-50.94%	-72.15%
% of Gross Profit
Depreciation & Amortization	$331.00	$460.00	$394.00
YoY Change	-28.2%	16.75%	19.39%
% of Gross Profit
Operating Expenses	$533.1K	$643.9K	$646.1K
YoY Change	-39.67%	-0.34%	-3.96%
Operating Profit	-$533.1K	-$643.9K	-$646.1K
YoY Change	-39.67%	-0.34%	-3.96%
Interest Expense	-$4.050K	-$74.68K	$85.29K
YoY Change	-115.68%	-187.57%	-172.83%
% of Operating Profit
Other Income/Expense, Net	-$5.026K	-$74.68K	-$83.91K
YoY Change	-119.46%	-11.0%	-100.83%
Pretax Income	-$538.2K	-$718.6K	-$730.0K
YoY Change	-37.27%	-1.56%	-107.73%
Income Tax
% Of Pretax Income
Net Earnings	-$538.1K	-$718.6K	-$730.0K
YoY Change	-37.27%	-1.56%	-107.73%
Net Earnings / Revenue
Basic Earnings Per Share	-$0.01	-$0.01	-$0.02
Diluted Earnings Per Share	-$0.01	-$0.01	-$0.02
COMMON SHARES
Basic Shares Outstanding	56.20M shares	48.80M shares	43.63M shares
Diluted Shares Outstanding	54.04M shares	48.75M shares	43.62M shares

Balance Sheet

Concept	2024 Q1	2023 Q4	2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$49.74K	$384.7K	$1.101M
YoY Change	-96.92%	-65.07%	-77.74%
Cash & Equivalents	$49.74K	$384.7K	$1.101M
Short-Term Investments
Other Short-Term Assets	$127.3K	$9.390K	$78.49K
YoY Change	6.87%	-88.04%	64.48%
Inventory
Prepaid Expenses	$121.3K	$3.394K	$77.49K
Receivables
Other Receivables
Total Short-Term Assets	$177.0K	$394.1K	$1.180M
YoY Change	-89.78%	-66.6%	-76.38%
LONG-TERM ASSETS
Property, Plant & Equipment	$9.342M	$9.111M	$3.836M
YoY Change	61.39%	137.5%	1103.56%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$9.393M	$9.177M	$3.956M
YoY Change	59.33%	131.96%	1141.22%
TOTAL ASSETS
Total Short-Term Assets	$177.0K	$394.1K	$1.180M
Total Long-Term Assets	$9.393M	$9.177M	$3.956M
Total Assets	$9.570M	$9.571M	$5.136M
YoY Change	25.47%	86.35%	-3.36%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.719M	$2.648M	$523.3K
YoY Change	239.47%	406.04%	146.52%
Accrued Expenses	$53.98K	$76.50K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$261.1K	$250.0K
YoY Change
Total Short-Term Liabilities	$4.467M	$4.200M	$1.237M
YoY Change	181.77%	239.39%	24.94%
LONG-TERM LIABILITIES
Long-Term Debt	$1.711M	$1.740M	$5.300M
YoY Change	-1.4%	-67.17%	4.42%
Other Long-Term Liabilities	$0.00	$0.00	$135.4K
YoY Change	-100.0%	-100.0%	10.46%
Total Long-Term Liabilities	$1.711M	$1.740M	$5.435M
YoY Change	-7.77%	-67.99%	4.56%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.467M	$4.200M	$1.237M
Total Long-Term Liabilities	$1.711M	$1.740M	$5.435M
Total Liabilities	$6.178M	$5.940M	$6.673M
YoY Change	79.55%	-10.99%	7.17%
SHAREHOLDERS EQUITY
Retained Earnings	-$129.2M	-$128.7M	-$125.7M
YoY Change	2.12%	2.39%
Common Stock	$0.00	$0.00	$0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$3.355M	$3.593M	-$1.574M
YoY Change
Total Liabilities & Shareholders Equity	$9.570M	$9.571M	$5.136M
YoY Change	25.47%	86.35%	-3.36%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2022 Q4
OPERATING ACTIVITIES
Net Income	-$538.1K	-$718.6K	-$730.0K
YoY Change	-37.27%	-1.56%	-107.73%
Depreciation, Depletion And Amortization	$331.00	$460.00	$394.00
YoY Change	-28.2%	16.75%	19.39%
Cash From Operating Activities	-$304.5K	-$50.65K	-$606.0K
YoY Change	-45.56%	-91.64%	20.48%
INVESTING ACTIVITIES
Capital Expenditures	$206.1K	$323.8K	$416.8K
YoY Change	-87.62%	-22.31%	-592.44%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$206.1K	-$323.8K	-$416.8K
YoY Change	-87.62%	-22.31%	392.44%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	175.6K	623.2K	226.2K
YoY Change	-93.58%	175.49%	-85.62%
NET CHANGE
Cash From Operating Activities	-304.5K	-50.65K	-606.0K
Cash From Investing Activities	-206.1K	-323.8K	-416.8K
Cash From Financing Activities	175.6K	623.2K	226.2K
Net Change In Cash	-335.0K	248.8K	-796.5K
YoY Change	-165.49%	-131.23%	-180.79%
FREE CASH FLOW
Cash From Operating Activities	-$304.5K	-$50.65K	-$606.0K
Capital Expenditures	$206.1K	$323.8K	$416.8K
Free Cash Flow	-$510.6K	-$374.5K	-$1.023M
YoY Change	-77.04%	-63.39%	144.49%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Entity Central Index Key EntityCentralIndexKey	0000875729
CY2023Q2	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent		usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent		usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue		usd
CY2023Q2	us-gaap	Common Stock Value CommonStockValue		usd
CY2023Q4	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax		usd
CY2022Q4	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax		usd
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax		usd
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax		usd
CY2023Q4	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest		usd
CY2022Q4	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest		usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest		usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest		usd
CY2023Q4	bnet	Warrants Exercised Under Cashless Exercise WarrantsExercisedUnderCashlessExercise		usd
	bnet	Warrants Exercised Under Cashless Exercise WarrantsExercisedUnderCashlessExercise		usd
	bnet	Commission On Sale Of Unit CommissionOnSaleOfUnit		usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt		usd
	us-gaap	Interest Paid Net InterestPaidNet		usd
	us-gaap	Interest Paid Net InterestPaidNet		usd
	bnet	Conversion Of Debt And Liabilities Into Notes Payable ConversionOfDebtAndLiabilitiesIntoNotesPayable		usd
	bnet	Conversion Of Notes Payable Into Shares ConversionOfNotesPayableIntoShares		usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	000-19333
	dei	Entity Registrant Name EntityRegistrantName	Bion Environmental Technologies, Inc.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	CO
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	84-1176672
	dei	Entity Address Address Line1 EntityAddressAddressLine1	9 East Park Court
	dei	Entity Address City Or Town EntityAddressCityOrTown	Old Bethpage
	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	11804
	dei	City Area Code CityAreaCode	516
	dei	Local Phone Number LocalPhoneNumber	586-5643
	dei	Security12b Title Security12bTitle	Common Stock
	dei	Trading Symbol TradingSymbol	BNET
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	56201815	shares
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	384735	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	625964	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	3394	usd
CY2023Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	16785	usd
CY2023Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	6000	usd
CY2023Q2	us-gaap	Deposits Assets Current DepositsAssetsCurrent	6000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	394129	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	648749	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	66090	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	93875	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	9110640	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	6851009	usd
CY2023Q4	us-gaap	Assets Assets	9570859	usd
CY2023Q2	us-gaap	Assets Assets	7593633	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	2648005	usd
CY2023Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	677136	usd
CY2023Q4	us-gaap	Deferred Compensation Liability Current DeferredCompensationLiabilityCurrent	1225226	usd
CY2023Q2	us-gaap	Deferred Compensation Liability Current DeferredCompensationLiabilityCurrent	864781	usd
CY2023Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	255407	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	71091	usd
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	75000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4199729	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	1616917	usd
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	29068	usd
CY2023Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	1740083	usd
CY2023Q2	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	1715970	usd
CY2023Q4	us-gaap	Liabilities Liabilities	5939812	usd
CY2023Q2	us-gaap	Liabilities Liabilities	3361955	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	50611962	shares
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	48044790	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	49907653	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	47340480	shares
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	132798923	usd
CY2023Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	131935418	usd
CY2023Q4	us-gaap	Common Stock Share Subscribed But Unissued Subscriptions Receivable CommonStockShareSubscribedButUnissuedSubscriptionsReceivable	504650	usd
CY2023Q2	us-gaap	Common Stock Share Subscribed But Unissued Subscriptions Receivable CommonStockShareSubscribedButUnissuedSubscriptionsReceivable	504650	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-128700799	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-127236663	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	3593474	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	4194105	usd
CY2023Q4	us-gaap	Minority Interest MinorityInterest	37573	usd
CY2023Q2	us-gaap	Minority Interest MinorityInterest	37573	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3631047	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	4231678	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	9570859	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	7593633	usd
CY2023Q4	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	636017	usd
CY2022Q4	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	630542	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1302272	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1497036	usd
CY2023Q4	us-gaap	Depreciation Depreciation	460	usd
CY2022Q4	us-gaap	Depreciation Depreciation	394	usd
	us-gaap	Depreciation Depreciation	921	usd
	us-gaap	Depreciation Depreciation	724	usd
CY2023Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	7431	usd
CY2022Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	15148	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	15730	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	43591	usd
CY2023Q4	us-gaap	Operating Expenses OperatingExpenses	643908	usd
CY2022Q4	us-gaap	Operating Expenses OperatingExpenses	646084	usd
	us-gaap	Operating Expenses OperatingExpenses	1318923	usd
	us-gaap	Operating Expenses OperatingExpenses	1541351	usd
CY2023Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-643908	usd
CY2022Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-646084	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1318923	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1541351	usd
CY2023Q4	us-gaap	Interest Income Operating InterestIncomeOperating	109	usd
CY2022Q4	us-gaap	Interest Income Operating InterestIncomeOperating	1375	usd
	us-gaap	Interest Income Operating InterestIncomeOperating	504	usd
	us-gaap	Interest Income Operating InterestIncomeOperating	3310	usd
CY2023Q4	bnet	Interests Expense InterestsExpense	74790	usd
CY2022Q4	bnet	Interests Expense InterestsExpense	85285	usd
	bnet	Interests Expense InterestsExpense	145717	usd
	bnet	Interests Expense InterestsExpense	111380	usd
CY2023Q4	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-74681	usd
CY2022Q4	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-83910	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-145213	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-108070	usd
CY2023Q4	us-gaap	Net Income Loss NetIncomeLoss	-718589	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	-729994	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1464136	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1649421	usd
CY2023Q4	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-718589	usd
CY2022Q4	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-729994	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1464136	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1649421	usd
CY2023Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
CY2023Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
CY2022Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
CY2022Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.02
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.03
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.04
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.04
CY2023Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	48748554	shares
CY2023Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	48748554	shares
CY2022Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	43620051	shares
CY2022Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	43620051	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	49321180	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	49321180	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	43533789	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	43533789	shares
CY2022Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-1133448	usd
CY2022Q4	bnet	Sale Of Units Value SaleOfUnitsValue	226230	usd
CY2022Q4	bnet	Issuance Of Warrants For Services IssuanceOfWarrantsForServices	32250	usd
CY2022Q4	bnet	Adjustment To Additional Paid In Capital Modification Of Warrants AdjustmentToAdditionalPaidInCapitalModificationOfWarrants	68088	usd
CY2022Q4	us-gaap	Profit Loss ProfitLoss	-729994	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-1536874	usd
CY2023Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3748542	usd
CY2023Q4	bnet	Sale Of Units Value SaleOfUnitsValue	375000	usd
CY2023Q4	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	48334	usd
CY2023Q4	bnet	Issuance Of Warrants For Services IssuanceOfWarrantsForServices	5000	usd
CY2023Q4	bnet	Vesting Of Options For Employees And Services VestingOfOptionsForEmployeesAndServices	52378	usd
CY2023Q4	bnet	Vesting Of Warrants For Employees And Services VestingOfWarrantsForEmployeesAndServices	3281	usd
CY2023Q4	bnet	Debt Modification DebtModification	-8430	usd
CY2023Q4	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	42500	usd
CY2023Q4	bnet	Adjustment To Additional Paid In Capital Modification Of Warrants AdjustmentToAdditionalPaidInCapitalModificationOfWarrants	89031	usd
CY2023Q4	bnet	Commission On Sale Of Units CommissionOnSaleOfUnits	-6000	usd
CY2023Q4	us-gaap	Profit Loss ProfitLoss	-718589	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3631047	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-894579	usd
	bnet	Sale Of Units Value SaleOfUnitsValue	546230	usd
	bnet	Warrants Exercised For Common Shares WarrantsExercisedForCommonShares	88375	usd
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	80000	usd
	bnet	Issuance Of Warrants For Services IssuanceOfWarrantsForServices	15000	usd
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	50000	usd
	bnet	Adjustment To Additional Paid In Capital Modification Of Warrants AdjustmentToAdditionalPaidInCapitalModificationOfWarrants	227521	usd
	us-gaap	Profit Loss ProfitLoss	-1649421	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-1536874	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	4231678	usd
	bnet	Sale Of Units Value SaleOfUnitsValue	420742	usd
	bnet	Warrants Exercised For Common Shares WarrantsExercisedForCommonShares	28500	usd
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	76320	usd
	bnet	Issuance Of Warrants For Services IssuanceOfWarrantsForServices	5000	usd
	bnet	Vesting Of Options For Employees And Services VestingOfOptionsForEmployeesAndServices	107487	usd
	bnet	Vesting Of Warrants For Employees And Services VestingOfWarrantsForEmployeesAndServices	6563	usd
	bnet	Debt Modification DebtModification	-16861	usd
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	91548	usd
	bnet	Adjustment To Additional Paid In Capital Modification Of Warrants AdjustmentToAdditionalPaidInCapitalModificationOfWarrants	150206	usd
	bnet	Commission On Sale Of Units CommissionOnSaleOfUnits	-6000	usd
	us-gaap	Profit Loss ProfitLoss	-1464136	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3631047	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1464136	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1649421	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	921	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	724	usd
	us-gaap	Other Noncash Expense OtherNoncashExpense	145717	usd
	us-gaap	Other Noncash Expense OtherNoncashExpense	43292	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	129048	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	223021	usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	81321	usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	127250	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-13391	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-80062	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	220699	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-949097	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-5192	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	32308	usd
	us-gaap	Increase Decrease In Deferred Compensation IncreaseDecreaseInDeferredCompensation	427583	usd
	us-gaap	Increase Decrease In Deferred Compensation IncreaseDecreaseInDeferredCompensation	170000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-450648	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1921861	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	483823	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	739486	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-483823	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-739486	usd
	bnet	Proceeds From Sale Of Units ProceedsFromSaleOfUnits	420742	usd
	bnet	Proceeds From Sale Of Units ProceedsFromSaleOfUnits	546230	usd
	bnet	Commission On Sale Of Unit CommissionOnSaleOfUnit	6000	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	250000	usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	28500	usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	56125	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	693242	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	602355	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-241229	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-2058992	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	625964	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3160442	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	384735	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1101450	usd
	bnet	Conversion Of Debt And Liabilities Into Common Units ConversionOfDebtAndLiabilitiesIntoCommonUnits	49048	usd
	bnet	Conversion Of Debt And Liabilities Into Common Units ConversionOfDebtAndLiabilitiesIntoCommonUnits	50000	usd
	bnet	Conversion Of Debt And Liabilities Into Notes Payable ConversionOfDebtAndLiabilitiesIntoNotesPayable	23943	usd
	bnet	Conversion Of Deferred Compensation To Notes Payable ConversionOfDeferredCompensationToNotesPayable	80767	usd
	bnet	Conversion Of Deferred Compensation To Notes Payable ConversionOfDeferredCompensationToNotesPayable	60000	usd
	bnet	Conversion Of Notes Payable Into Shares ConversionOfNotesPayableIntoShares	91548	usd
	bnet	Purchase Of Property And Equipment For Accounts Payable PurchaseOfPropertyAndEquipmentForAccountsPayable	1750170	usd
	bnet	Purchase Of Property And Equipment For Accounts Payable PurchaseOfPropertyAndEquipmentForAccountsPayable	135673	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4200000	usd
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	2600000	usd
CY2023Q4	bnet	Initial Tranche InitialTranche	250000	usd
	bnet	Techwastage Techwastage	1500	decimal
CY2022Q1	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	2665500	usd
CY2022Q1	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.25	pure
CY2022Q1	us-gaap	Debt Instrument Periodic Payment DebtInstrumentPeriodicPayment	666375	usd
CY2022Q2	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.25	pure
CY2023Q1	us-gaap	Debt Instrument Periodic Payment DebtInstrumentPeriodicPayment	533100	usd
CY2023Q2	us-gaap	Debt Instrument Periodic Payment DebtInstrumentPeriodicPayment	83275	usd
CY2023Q2	bnet	Aggregate Payment AggregatePayment	2615500	usd
CY2023Q3	bnet	Purchase Order PurchaseOrder	50000	usd
	bnet	Additional Interest Costs Incurred Capitalized AdditionalInterestCostsIncurredCapitalized	6442812	usd
	bnet	Interest Costs Capitalized Paid InterestCostsCapitalizedPaid	6983954	usd
	us-gaap	Interest Costs Capitalized Adjustment InterestCostsCapitalizedAdjustment	1750170	usd
	us-gaap	Interest Costs Incurred InterestCostsIncurred	8177452	usd
	bnet	Percentage Of Sustainable PercentageOfSustainable	0.295	pure
	bnet	Description Of Kreider2 Poultry Project DescriptionOfKreider2PoultryProject	Bion has done extensive pre-development work related to a waste treatment/renewable energy production facility to treat the waste from KF’s approximately 6+ million chickens (planned to expand to approximately 9-10 million) (and potentially other poultry operations and/or other waste streams) (‘Kreider Renewable Energy Facility’ or ‘Kreider 2 Project’). On May 5, 2016, the Company executed a stand-alone joint venture agreement (“JVA”) with Kreider Farms covering all matters related to development and operation of Kreider 2 system to treat the waste streams from Kreider’s poultry facilities in Bion PA2 LLC (“PA2”). Now that development of the Company’s Gen3Tech is being deployed, the Company has commenced discussions with KF regarding updating and amending the JV agreement and anticipates executing an amended joint venture agreement during 2023. During May 2011 the PADEP certified a smaller version of the Kreider 2 Project (utilizing our 2nd generation technology) under the old EPA’s Chesapeake Bay model. The Company anticipates that if and when new designs are finalized utilizing our Gen3Tech, a larger Kreider 2 Project will be re-certified for a far larger number of credits (management’s current estimates are between 2-4 million (or more) nutrient reduction credits for treatment of the waste stream from Kreider’s poultry pursuant to the amended EPA Chesapeake Bay model and agreements between the EPA and PA).
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	1464000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	1649000	usd
CY2023Q4	bnet	Working Capital Deficit WorkingCapitalDeficit	3806000	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	8291000	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	3189000	usd
CY2022	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	10235000	usd
CY2022	bnet	Gain On Sale Of Domain Amount GainOnSaleOfDomainAmount	902000	usd
CY2023	bnet	Reduction Of Debt ReductionOfDebt	3516000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4200000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1600000	usd
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	2600000	usd
CY2023	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	4038000	usd
CY2022	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	1737000	usd
	bnet	Payments To Warrant Exercises Commissions PaymentsToWarrantExercisesCommissions	86000	usd
	bnet	Payments To Warrant Exercises Commissions PaymentsToWarrantExercisesCommissions	19000	usd
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	443000	usd
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	602000	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	250000	usd
CY2023Q4	bnet	Deferred Compensation Liability Amount Cancelled DeferredCompensationLiabilityAmountCancelled	1250000	usd
CY2018	bnet	Deferred Compensation Liability Amount Cancelled DeferredCompensationLiabilityAmountCancelled	2404000	usd
	bnet	Reduction Of Debt ReductionOfDebt	3516000	usd
CY2023Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2023Q2	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2023Q4	bnet	Weighted Average Number Of Diluted Share Outstanding WeightedAverageNumberOfDilutedShareOutstanding	48879433	shares
CY2022Q4	bnet	Weighted Average Number Of Diluted Share Outstanding WeightedAverageNumberOfDilutedShareOutstanding	43620051	shares
	bnet	Weighted Average Number Of Diluted Share Outstanding WeightedAverageNumberOfDilutedShareOutstanding	48748554	shares
	bnet	Weighted Average Number Of Diluted Share Outstanding WeightedAverageNumberOfDilutedShareOutstanding	43533789	shares
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_848_eus-gaap--ConcentrationRiskCreditRisk_zUVU9AdDhdck" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_867_zFlYHc1REXEk">Concentrations of credit risk:</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company's financial instruments that are exposed to concentrations of credit risk consist of cash. The Company's cash is in demand deposit accounts placed with federally insured financial institutions and selected brokerage accounts. Such deposit accounts at times may exceed federally insured limits. The Company has not experienced any losses on such accounts.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_841_eus-gaap--UseOfEstimates_zxWXfYRtx0Qe" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><span id="xdx_860_z0JnsqRZ7rx2">Use of estimates:</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In preparing the Company’s condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States of America, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p>
CY2023Q4	bnet	Shares Issued Beginning Of Period SharesIssuedBeginningOfPeriod	49485556	shares
CY2022Q4	bnet	Shares Issued Beginning Of Period SharesIssuedBeginningOfPeriod	44303654	shares
	bnet	Shares Issued Beginning Of Period SharesIssuedBeginningOfPeriod	48880237	shares
	bnet	Shares Issued Beginning Of Period SharesIssuedBeginningOfPeriod	43758820	shares
CY2023Q4	bnet	Shares Held By Subsidiaries SharesHeldBySubsidiaries	-704309	shares
CY2022Q4	bnet	Shares Held By Subsidiaries SharesHeldBySubsidiaries	-704309	shares
	bnet	Shares Held By Subsidiaries SharesHeldBySubsidiaries	-704309	shares
	bnet	Shares Held By Subsidiaries SharesHeldBySubsidiaries	-704309	shares
CY2023Q4	bnet	Shares Outstanding Beginning Of Period SharesOutstandingBeginningOfPeriod	48781247	shares
CY2022Q4	bnet	Shares Outstanding Beginning Of Period SharesOutstandingBeginningOfPeriod	43599345	shares
	bnet	Shares Outstanding Beginning Of Period SharesOutstandingBeginningOfPeriod	48175928	shares
	bnet	Shares Outstanding Beginning Of Period SharesOutstandingBeginningOfPeriod	43054511	shares
CY2023Q4	bnet	Weighted Average Shares Issued During Period WeightedAverageSharesIssuedDuringPeriod	98186	shares
CY2022Q4	bnet	Weighted Average Shares Issued During Period WeightedAverageSharesIssuedDuringPeriod	20706	shares
	bnet	Weighted Average Shares Issued During Period WeightedAverageSharesIssuedDuringPeriod	572626	shares
	bnet	Weighted Average Shares Issued During Period WeightedAverageSharesIssuedDuringPeriod	479278	shares
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	9123468	usd
CY2023Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	6862916	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	12828	usd
CY2023Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	11907	usd
CY2023Q4	us-gaap	Property Plant And Equipment Other Net PropertyPlantAndEquipmentOtherNet	9110640	usd
CY2023Q2	us-gaap	Property Plant And Equipment Other Net PropertyPlantAndEquipmentOtherNet	6851009	usd
	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	238540	usd
	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	98104	usd
	bnet	Non Cash Compensation NonCashCompensation	135648	usd
	bnet	Non Cash Compensation NonCashCompensation	135648	usd
CY2023Q4	us-gaap	Depreciation Depreciation	460	usd
CY2022Q4	us-gaap	Depreciation Depreciation	394	usd
	us-gaap	Depreciation Depreciation	921	usd
	us-gaap	Depreciation Depreciation	724	usd
CY2023Q4	us-gaap	Deferred Compensation Liability Current DeferredCompensationLiabilityCurrent	1225226	usd
CY2022Q4	us-gaap	Deferred Compensation Liability Current DeferredCompensationLiabilityCurrent	714222	usd
CY2023Q4	bnet	Interest Rate On Deferred Compensation InterestRateOnDeferredCompensation	0.04	pure
	bnet	Deferred Compensation Consecutive Trading Days DeferredCompensationConsecutiveTradingDays	P10D
CY2023Q4	us-gaap	Deferred Compensation Liability Current And Noncurrent DeferredCompensationLiabilityCurrentAndNoncurrent	255000	usd
CY2022Q4	us-gaap	Deferred Compensation Liability Current And Noncurrent DeferredCompensationLiabilityCurrentAndNoncurrent	80000	usd
CY2021Q3	us-gaap	Assets Assets	297	usd
CY2021Q3	us-gaap	Liabilities Liabilities	10154334	usd
CY2021Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	9939148	usd
CY2021Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	214235	usd
CY2021Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	950	usd
CY2021Q4	us-gaap	Liabilities Liabilities	10234501	usd
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	10009802	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	212263	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	12436	usd
	us-gaap	Gain Or Loss On Sale Of Stock In Subsidiary GainOrLossOnSaleOfStockInSubsidiary	10234501	usd
CY2021Q2	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	9868495	usd
CY2023Q4	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	0.50
	us-gaap	Costs Incurred Development Costs CostsIncurredDevelopmentCosts	26559	usd
	us-gaap	Costs Incurred Development Costs CostsIncurredDevelopmentCosts	66104	usd
CY2023Q1	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	3470000	usd
CY2023Q4	bnet	Initial Tranche InitialTranche	250000	usd
CY2023Q1	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	3470000	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	3522000	usd
CY2023	bnet	Reduction Of Additional Paid In Capital ReductionOfAdditionalPaidInCapital	14051	usd
	bnet	Debt Modifications DebtModifications	16861	usd
	bnet	Shares Held By Subsidiaries SharesHeldBySubsidiaries	-704309	shares
	bnet	Class Of Warrant Or Right Exercised During Period ClassOfWarrantOrRightExercisedDuringPeriod	38000	shares
	bnet	Common Stock Shares Issued Upon Exercise Of Warrants CommonStockSharesIssuedUponExerciseOfWarrants	38000	shares
	bnet	Total Proceeds TotalProceeds	28500	usd
CY2023Q4	bnet	Exercise Bonus ExerciseBonus	0.75	pure
CY2023Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	24000000	shares
CY2023Q3	bnet	Sale Of Warrants SaleOfWarrants	1003590	shares
CY2023Q3	us-gaap	Warrant Exercise Price Increase WarrantExercisePriceIncrease	1.25
CY2023Q3	us-gaap	Shares Issued SharesIssued	501795	shares
CY2023Q3	us-gaap	Warrants And Rights Outstanding Maturity Date WarrantsAndRightsOutstandingMaturityDate	2023-10-01
	bnet	Class Of Warrant Or Right Exercised During Period ClassOfWarrantOrRightExercisedDuringPeriod	38000	shares
	bnet	Common Stock Shares Issued Upon Exercise Of Warrants CommonStockSharesIssuedUponExerciseOfWarrants	38000	shares
	bnet	Warrants Exercised For Common Stock WarrantsExercisedForCommonStock	28500	usd
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	12006600	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.85
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P1Y9M29D
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	5085659	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	12006600	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.85
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P1Y3M25D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	1778547	usd
CY2022Q2	bnet	Compensation Increased CompensationIncreased	25000	usd
CY2021Q2	bnet	Exercise Bonus ExerciseBonus	0.75	pure
CY2021Q2	bnet	Warrants Held By Trust Owned Shares WarrantsHeldByTrustOwnedShares	3000000	shares
CY2023Q4	bnet	Warrants And Rights Outstanding Shares WarrantsAndRightsOutstandingShares	20415408	shares
CY2022Q1	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	2665500	usd
CY2022Q1	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.25	pure
CY2022Q1	us-gaap	Debt Instrument Periodic Payment DebtInstrumentPeriodicPayment	666375	usd
CY2022Q1	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.25	pure
CY2022Q2	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.25	pure
CY2023Q1	us-gaap	Debt Instrument Periodic Payment DebtInstrumentPeriodicPayment	533100	usd
CY2023Q2	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	83275	usd
CY2023Q2	bnet	Aggregate Payment AggregatePayment	2615500	usd
CY2022Q2	bnet	Purchase Order PurchaseOrder	50000	usd
	us-gaap	Interest Costs Incurred Capitalized InterestCostsIncurredCapitalized	6442812	usd
	bnet	Interest Costs Capitalized Paid InterestCostsCapitalizedPaid	6983954	usd
	us-gaap	Interest Costs Capitalized Adjustment InterestCostsCapitalizedAdjustment	1750170	usd
	bnet	Interests Costs Incurred Capitalized InterestsCostsIncurredCapitalized	8177452	usd
CY2023Q4	bnet	Operating Leases Future Minimum Payment Receivable In Two Years OperatingLeasesFutureMinimumPaymentReceivableInTwoYears	75000	usd
CY2023Q4	bnet	Undiscounted Cash Flow UndiscountedCashFlow	75000	usd
CY2023Q4	bnet	Less Imputed Interest LessImputedInterest	-3909	usd
CY2023Q4	bnet	Capital Lease Contingent Rental Payments Due CapitalLeaseContingentRentalPaymentsDue	71091	usd
CY2022Q1	bnet	Sale Of Domain Description SaleOfDomainDescription	the Company entered into an agreement to sell domain name <biontech.com> and other related assets to BioNTech SE (“BNTX”) for the sum of $950,000 (before expenses related to the transaction) which sale was closed/completed on April 2, 2022 with a one-time gain of $902,490.
CY2021Q4	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	2255802	usd
CY2021Q3	us-gaap	Assets Assets	297	usd
CY2021Q3	us-gaap	Liabilities Liabilities	10154334	usd
CY2021Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	9939148	usd
CY2021Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	214235	usd
CY2021Q4	us-gaap	Liabilities Liabilities	10234501	usd
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	10009802	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	12436	usd
	us-gaap	Extinguishment Of Debt Gain Loss Net Of Tax ExtinguishmentOfDebtGainLossNetOfTax	10234501	usd
CY2021Q2	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	9868495	usd
CY2023Q2	bnet	Bank Account Hacked Amount BankAccountHackedAmount	75000	usd
CY2023Q4	bnet	Initial Tranche InitialTranche	250000	usd
CY2024Q1	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	9108312	usd

Files In Submission

Name	View Source	Status
0001079973-24-000236-index-headers.html	Edgar Link	pending
0001079973-24-000236-index.html	Edgar Link	pending
0001079973-24-000236.txt	Edgar Link	pending
0001079973-24-000236-xbrl.zip	Edgar Link	pending
bion_10q.htm	Edgar Link	pending
bnet-20231231.xsd	Edgar Link	pending
bnet-20231231_def.xml	Edgar Link	unprocessable
bnet-20231231_lab.xml	Edgar Link	unprocessable
bnet-20231231_pre.xml	Edgar Link	unprocessable
bion_10q_htm.xml	Edgar Link	completed
ex31x1.htm	Edgar Link	pending
ex31x2.htm	Edgar Link	pending
ex32x1.htm	Edgar Link	pending
ex32x2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
bnet-20231231_cal.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BNET
BION ENVIRONMENTAL TECHNOLOGIES INC Stock $bnet

2024 Q1 Form 10-Q Financial Statement

#000107997324000236 Filed on February 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BNET BION ENVIRONMENTAL TECHNOLOGIES INC Stock $bnet

2024 Q1 Form 10-Q Financial Statement

#000107997324000236 Filed on February 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BNET
BION ENVIRONMENTAL TECHNOLOGIES INC Stock $bnet